Italy Pharmaceuticals & Healthcare Q1 2019
Italy’s pharmaceutical market will continue to expand over the forecast period, driven by the rising demand for treatmentby an ageing population as well as the introduction of new innovative therapies. Although this will translate into renewedcommercial opportunities for drugmakers, operating conditions will remain challenging due to cost-control measures targetingpharmaceutical and healthcare spending. In fact, despite the new government’s populist leaning, fiscal loosening will not translateinto a retrenchment from austerity measures aimed at controlling rising healthcare costs. Meanwhile, Italy's pharmaceuticalproduction and exports will continue to observe robust growth over the coming years.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook